Skip to main content
Clinical Trials/NCT07002580
NCT07002580
Recruiting
Not Applicable

Evaluation of the Effectiveness of iPACK (Local Anesthetic Infiltration of the Interspace Between the Popliteal Artery and the Posterior Knee Capsule) and Adductor Canal Blocks on Quality of Recovery in Patients Undergoing Arthroscopic Knee Surgery

Sakarya University1 site in 1 country64 target enrollmentStarted: July 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Sakarya University
Enrollment
64
Locations
1
Primary Endpoint
Quality of Recovery

Overview

Brief Summary

Arthroscopic knee surgery is one of the most commonly performed procedures in orthopedic surgery. More than 50% of patients experience moderate to severe pain after the operation. Inadequate postoperative pain control and poor recovery quality can negatively impact physiotherapy protocols, prolong hospital stays, and consequently lead to cognitive dysfunction, systemic infections, and increased healthcare costs.

Therefore, reducing postoperative pain and improving recovery quality are of great importance. In our clinic, a variety of analgesic techniques are routinely employed as part of a multimodal analgesia approach for patients undergoing arthroscopic knee surgery. One of these techniques is the simultaneous application of the IPACK block and the adductor canal block.

In this study, we aim to evaluate the effectiveness of these blocks on postoperative recovery quality in patients undergoing arthroscopic knee surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Masking Description

Patients will be randomized with closed letter method.

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients aged between 18 and 50 years,
  • Scheduled for arthroscopic knee surgery under spinal anesthesia due to knee pathology
  • Patients classified as ASA physical status I-II-III according to the American Society of Anesthesiologists risk classification

Exclusion Criteria

  • Coagulopathy
  • ASA IV-V patients
  • Uncooperable patients
  • Patients who refuses to participate in study
  • Patients who takes chronic pain treatments

Arms & Interventions

Group 1

Experimental

Group 1 will involve the patients which will be applied iPACK and adductor canal blocks in addition to spinal anesthesia.

Intervention: IPACK and adductor canal block with Bupivacaine 0.25% (Procedure)

Group 1

Experimental

Group 1 will involve the patients which will be applied iPACK and adductor canal blocks in addition to spinal anesthesia.

Intervention: Spinal Anesthesia with Bupivacaine (Procedure)

Group 2

Experimental

Group 2 will involve the patients which will be applied only spinal anesthesia without additional peripheric nerve blocks.

Intervention: Spinal Anesthesia with Bupivacaine (Procedure)

Outcomes

Primary Outcomes

Quality of Recovery

Time Frame: 24 hours.

Quality of Recovery of the patients will be assessed with QoR-15 questionnaire. Its scoring will range between 0 and 150 points.

Secondary Outcomes

  • Analgesic Consumption(24 hours.)

Investigators

Sponsor
Sakarya University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Oguzhan Okumus

Resident M.D.

Sakarya University

Study Sites (1)

Loading locations...

Similar Trials